• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

佩罗尼氏病患者的富血小板血浆

Platelet-rich plasma in patients affected with Peyronie's disease.

作者信息

Achraf Chatar, Abdelghani Pr Ammani, Jihad Pr El Anzaoui

机构信息

Urology department, CHU Hassan II, Fes, Morocco.

Military Hospital Moulay Ismail, Meknes, Morocco.

出版信息

Arab J Urol. 2022 Oct 25;21(2):69-75. doi: 10.1080/2090598X.2022.2135284. eCollection 2023.

DOI:10.1080/2090598X.2022.2135284
PMID:37234679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10208162/
Abstract

OBJECTIVES

The objective of our study is to discover and evaluate the effects of repeated intralesional injections inside the tunica albuginea of platelet-rich plasma (PRP) in the treatment of Peyronie's disease (PD).

METHODS

As part of a prospective study over 12 months from February 2020 until February 2021, on Sixty-five patients with Peyronie's disease, and penile curvature between 25 and 45°. Patients were stratified into two groups, the first with a curvature between 25 and 35° and the second between 35 and 45°. Gathered data included patient-demographics, Injection technique, outcomes: both quantitative (curvature assessments) and qualitative (state of erectile function, pain during intercourse), and complications.

UNLABELLED

Patients in both groups received an average of 6.1 injections of PRP during the study period. Angulation was significantly improved in both groups an average final improvement of 16.88° (SD = 3.35) (p < 0.001) in the first group and 17.27° (SD = 4.22) (p < 0.001) in the second group. Pain during sex decreased from 70.7% to 34.25%, and 55.5% of patients had easier sexual intercourse.

UNLABELLED

The positive results of our series of treatment for Peyronie's disease by injection of platelet-rich plasma are encouraging both methodologically (simplicity) and clinical (safety and efficacy) as well as patient satisfaction.

摘要

目的

我们研究的目的是发现并评估在白膜内重复注射富血小板血浆(PRP)治疗佩罗尼氏病(PD)的效果。

方法

作为一项前瞻性研究的一部分,从2020年2月至2021年2月历时12个月,研究对象为65例佩罗尼氏病患者,阴茎弯曲度在25至45°之间。患者被分为两组,第一组弯曲度在25至35°之间,第二组在35至45°之间。收集的数据包括患者人口统计学信息、注射技术、结果:包括定量(弯曲度评估)和定性(勃起功能状态、性交时疼痛)以及并发症。

未标注

在研究期间,两组患者平均接受了6.1次PRP注射。两组的角度均有显著改善,第一组平均最终改善16.88°(标准差=3.35)(p<0.001),第二组平均最终改善17.27°(标准差=4.22)(p<0.001)。性交时疼痛从70.7%降至34.25%,55.5%的患者性交变得更容易。

未标注

我们通过注射富血小板血浆治疗佩罗尼氏病的系列治疗结果在方法学上(简单性)、临床方面(安全性和有效性)以及患者满意度方面都令人鼓舞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0543/10208162/5b380a06548c/TAJU_A_2135284_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0543/10208162/5b380a06548c/TAJU_A_2135284_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0543/10208162/5b380a06548c/TAJU_A_2135284_F0001_OC.jpg

相似文献

1
Platelet-rich plasma in patients affected with Peyronie's disease.佩罗尼氏病患者的富血小板血浆
Arab J Urol. 2022 Oct 25;21(2):69-75. doi: 10.1080/2090598X.2022.2135284. eCollection 2023.
2
Tolerance and efficacy of platelet-rich plasma injections in Peyronie's disease: Pilot study.富血小板血浆注射治疗佩罗尼氏病的耐受性和疗效:初步研究。
Prog Urol. 2022 Oct;32(12):856-861. doi: 10.1016/j.purol.2022.05.004. Epub 2022 Jun 28.
3
Surgical Outcomes of Plaque Excision and Grafting and Supplemental Tunica Albuginea Plication for Treatment of Peyronie's Disease With Severe Compound Curvature.严重复合弯曲型 Peyronie 病采用斑块切除和移植物植入及补充白膜折叠术的手术治疗效果。
J Sex Med. 2018 Jul;15(7):1021-1029. doi: 10.1016/j.jsxm.2018.04.642. Epub 2018 May 22.
4
Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.局部应用前列环素类似物伊洛前列素治疗 Peyronie 病患者的安全性和耐受性:I 期研究。
BJU Int. 2012 Jul;110(1):117-21. doi: 10.1111/j.1464-410X.2011.10733.x. Epub 2011 Dec 16.
5
Sildenafil 25 mg ODT + Collagenase Clostridium hystoliticum vs Collagenase Clostridium hystoliticum Alone for the Management of Peyronie's Disease: A Matched-Pair Comparison Analysis.西地那非 25 毫克口腔崩解片+胶原酶梭菌组织溶解酶与单独使用胶原酶梭菌组织溶解酶治疗阴茎硬结症的比较:配对比较分析。
J Sex Med. 2018 Oct;15(10):1472-1477. doi: 10.1016/j.jsxm.2018.08.012. Epub 2018 Sep 20.
6
Efficacy of Collagenase Clostridium histolyticum (Xiapex) in Patients with the Acute Phase of Peyronie's Disease.胶原酶(希美加)治疗急性期 Peyronie 病的疗效。
Clin Drug Investig. 2020 Jun;40(6):583-588. doi: 10.1007/s40261-020-00916-4.
7
New protocol in the treatment of Peyronie's disease by combining platelet-rich plasma, percutaneous needle tunneling, and penile modeling: Preliminary results.通过联合富血小板血浆、经皮针隧道技术和阴茎塑形治疗佩罗尼氏病的新方案:初步结果。
Fr J Urol. 2024 Jan;34(1):102526. doi: 10.1016/j.purol.2023.09.013. Epub 2023 Sep 28.
8
Review of Management Options for Patients With Atypical Peyronie's Disease.《不典型性佩罗尼病患者的治疗选择综述》。
Sex Med Rev. 2017 Apr;5(2):211-221. doi: 10.1016/j.sxmr.2016.07.004. Epub 2016 Aug 17.
9
Factors Associated With Erectile Dysfunction and the Peyronie's Disease Questionnaire in Patients With Peyronie Disease.佩罗尼氏病患者勃起功能障碍相关因素及佩罗尼氏病问卷分析
Urology. 2017 Sep;107:155-160. doi: 10.1016/j.urology.2017.05.029. Epub 2017 May 26.
10
A phase 2 randomized, placebo-controlled crossover trial to evaluate safety and efficacy of platelet-rich plasma injections for Peyronie's disease: clinical trial update.一项评估富血小板血浆注射治疗佩罗尼氏病安全性和有效性的2期随机、安慰剂对照交叉试验:临床试验更新
Int J Impot Res. 2024 Dec;36(8):813-817. doi: 10.1038/s41443-024-00844-3. Epub 2024 Feb 29.

引用本文的文献

1
Platelet-rich plasma intra-plaque injections rapidly reduce penile curvature and improve sexual function in Peyronie's disease patients: results from a prospective large-cohort study.富血小板血浆斑块内注射可迅速减轻佩罗尼氏病患者的阴茎弯曲并改善性功能:一项前瞻性大队列研究的结果
World J Urol. 2025 May 15;43(1):306. doi: 10.1007/s00345-025-05691-5.
2
Efficacy of platelet-rich plasma in the treatment of erectile dysfunction: A meta-analysis of controlled and single-arm trials.富血小板血浆治疗勃起功能障碍的疗效:对照和单臂试验的荟萃分析。
PLoS One. 2024 Nov 14;19(11):e0313074. doi: 10.1371/journal.pone.0313074. eCollection 2024.
3

本文引用的文献

1
Sexual function outcomes and risk factors of erectile dysfunction after surgical repair of penile fracture.阴茎骨折手术修复后勃起功能障碍的性功能结局及危险因素
Turk J Urol. 2021 Mar;47(2):106-112. doi: 10.5152/tud.2020.20311. Epub 2020 Oct 9.
2
Non-conventional therapies for Peyronie's disease: what is the evidence for efficacy?佩罗尼氏病的非常规治疗方法:疗效证据有哪些?
Transl Androl Urol. 2020 Mar;9(Suppl 2):S295-S302. doi: 10.21037/tau.2019.09.36.
3
Minimally invasive therapies for Peyronie's disease: the current state of the art.
Intralesional and topical treatments for Peyronie's disease: a narrative review of current knowledge.
佩罗尼氏病的病灶内和局部治疗:当前知识的叙述性综述
Asian J Androl. 2025 Mar 1;27(2):156-165. doi: 10.4103/aja202460. Epub 2024 Aug 23.
4
Evidence of restorative therapies in the treatment of Peyronie disease: A narrative review.在 Peyronie 病治疗中修复疗法的证据:叙事性综述。
Int Braz J Urol. 2024 Nov-Dec;50(6):703-713. doi: 10.1590/S1677-5538.IBJU.2024.9920.
5
Platelet-rich plasma therapy in erectile dysfunction and Peyronie's disease: a systematic review of the literature.富血小板血浆疗法治疗勃起功能障碍和 Peyronie 病:文献系统评价。
World J Urol. 2024 May 29;42(1):359. doi: 10.1007/s00345-024-05065-3.
6
A phase 2 randomized, placebo-controlled crossover trial to evaluate safety and efficacy of platelet-rich plasma injections for Peyronie's disease: clinical trial update.一项评估富血小板血浆注射治疗佩罗尼氏病安全性和有效性的2期随机、安慰剂对照交叉试验:临床试验更新
Int J Impot Res. 2024 Dec;36(8):813-817. doi: 10.1038/s41443-024-00844-3. Epub 2024 Feb 29.
佩罗尼氏病的微创治疗:当前的技术水平
Transl Androl Urol. 2020 Mar;9(Suppl 2):S269-S283. doi: 10.21037/tau.2019.08.06.
4
Anti-fibrotic effect of mycophenolate mofetil on Peyronie's disease experimentally induced with TGF-β.霉酚酸酯对 TGF-β诱导的实验性佩罗尼病的抗纤维化作用。
Int J Impot Res. 2020 Mar;32(2):201-206. doi: 10.1038/s41443-019-0138-7. Epub 2019 Apr 18.
5
Extracorporeal Shock Wave Therapy in Peyronie's Disease: Clinical Efficacy and Safety from a Single-Arm Observational Study.佩罗尼氏病的体外冲击波疗法:一项单臂观察性研究的临床疗效与安全性
World J Mens Health. 2019 Sep;37(3):339-346. doi: 10.5534/wjmh.180100. Epub 2019 Mar 26.
6
The Effect of Platelet-Rich Plasma on Peyronie's Disease in Rat Model.富血小板血浆对大鼠佩罗尼氏病模型的影响。
Urol Int. 2019;102(2):218-223. doi: 10.1159/000492755. Epub 2018 Oct 12.
7
2018 Canadian Urological Association guideline for Peyronie's disease and congenital penile curvature.2018年加拿大泌尿外科协会佩罗尼氏病和先天性阴茎弯曲指南。
Can Urol Assoc J. 2018 May;12(5):E197-E209. doi: 10.5489/cuaj.5255. Epub 2018 Feb 22.
8
Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions.富血小板纤维蛋白基质注射治疗常见泌尿科疾病的安全性和可行性。
Investig Clin Urol. 2018 Jan;59(1):61-65. doi: 10.4111/icu.2018.59.1.61. Epub 2017 Dec 21.
9
Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double-blinded, randomized study.与维拉帕米相比,病灶内注射透明质酸治疗佩罗尼氏病的评估:一项前瞻性、双盲、随机研究的初步结果
Andrology. 2017 Jul;5(4):771-775. doi: 10.1111/andr.12368.
10
The combination of nano-calcium sulfate/platelet rich plasma gel scaffold with BMP2 gene-modified mesenchymal stem cells promotes bone regeneration in rat critical-sized calvarial defects.纳米硫酸钙/富血小板血浆凝胶支架与BMP2基因修饰的间充质干细胞联合应用可促进大鼠颅骨临界尺寸缺损的骨再生。
Stem Cell Res Ther. 2017 May 25;8(1):122. doi: 10.1186/s13287-017-0574-6.